Reply by Authors.

Abstract

No AccessJournal of UrologyAdult Urology1 Aug 2022Reply by Authorsis a reply to letterEditorial Comment Kelly K. Bree, Patrick J. Hensley, Niyati Lobo, Nathan A. Brooks, Graciela M. Nogueras-Gonzalez, Charles C. Guo, Neema Navai, H. Barton Grossman, Colin P. Dinney, and Ashish M. Kamat Kelly K. BreeKelly K. Bree https://orcid.org/0000-0003-4532-7763 Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Patrick J. HensleyPatrick J. Hensley Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Niyati LoboNiyati Lobo Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Nathan A. BrooksNathan A. Brooks UPMC Urology of Central Pennsylvania, Harrisburg, Pennsylvania More articles by this author , Graciela M. Nogueras-GonzalezGraciela M. Nogueras-Gonzalez Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Charles C. GuoCharles C. Guo Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Neema NavaiNeema Navai Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , H. Barton GrossmanH. Barton Grossman Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , Colin P. DinneyColin P. Dinney Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author , and Ashish M. KamatAshish M. Kamat *Correspondence: Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1373, Houston, Texas 77030 (telephone: 713-792-3250; FAX: 713-794-4824; E-mail Address: [email protected] Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002678.02AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 208(2), pp. 290–291 Reference 1. : Primary Ta high grade bladder tumors: determination of the risk of progression. Urol Oncol 2021; 39: 132.e. Google Scholar Editor's Note: This article is the second of 5 published in this issue for which Category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 487 and 488. See Editorial on page 239. © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyJun 30, 2022, 12:00:00 AMEditorial Comment Volume 208Issue 2August 2022Page: 290-291 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Kelly K. Bree Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Patrick J. Hensley Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Niyati Lobo Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Nathan A. Brooks UPMC Urology of Central Pennsylvania, Harrisburg, Pennsylvania More articles by this author Graciela M. Nogueras-Gonzalez Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Charles C. Guo Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Neema Navai Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author H. Barton Grossman Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Colin P. Dinney Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Ashish M. Kamat Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas *Correspondence: Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1373, Houston, Texas 77030 (telephone: 713-792-3250; FAX: 713-794-4824; E-mail Address: [email protected] More articles by this author Expand All Editor's Note: This article is the second of 5 published in this issue for which Category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 487 and 488. See Editorial on page 239. Advertisement PDF DownloadLoading ...